Hims & Hers: Wegovy Deal Opens New Growth Chapter - Missed The Rally? Selling Puts Could Yield 30%

seekingalpha.com/article/4785464-hims-and-hers-wegovy-deal-opens-new-growth-chapter-missed-the-rally-selling-puts-could-yield-30-percent

Summary
- Hims & Hers Health rebounded from a 60% stock drop by partnering with Novo Nordisk, offering Wegovy at a competitive price, boosting accessibility and growth.
- Q1 earnings were exceptional with 111% YoY revenue growth and a 345% increase in net income, highlighting a…

This story appeared on seekingalpha.com, 2025-05-12 06:40:48.
The Entire Business World on a Single Page. Free to Use →